Orexo AB
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Orexo AB
Orexo AB has operations in Sweden and the United States. Operations are monitored and presented in the segments USA Pharma, Digital Therapeutics (DTx), and HQ & Pipeline. The majority is from the USA Pharma segment. Geographically, the majority is derived from the United States. USA Pharma includes the commercialization of fully owned pharmaceuticals in the United States market. Digital Therapeutics include the commercialization of Orexo’s groundbreaking evidence-based digital therapeutics, mainly in the United States market, which is in an early development stage. HQ &Pipeline includes the Development of pharmaceuticals performed at Orexo’s headquarters in Uppsala, Sweden.
/ 
Others were interested in
Frequently asked questions
To buy Orexo AB stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Orexo AB by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Orexo AB is ORX:xome. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Orexo AB has its primary listing on NASDAQ OMX Stockholm. You can trade Orexo AB with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Orexo AB is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Orexo AB as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Orexo AB.